Author: Bella Hayes
New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Customers Bancorp, Inc. (NYSE: NYSE:) between March 1, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the January 31, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Customers Bancorp securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join…
MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX; : TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX250-CDx (Zircaix ®1, 89Zr- girentuximab) kidney cancer imaging2. TLX250-CDx is an investigational PET3 drug product for the non-invasive diagnosis and characterization of clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer. If approved, TLX250-CDx will be the first and only targeted PET agent specifically for kidney cancer to be commercially available in…
New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DMC Global Inc. (NASDAQ: NASDAQ:) between May 3, 2024 and November 4, 2024, both dates inclusive (the “Class Period”), of the important February 4, 2025 lead plaintiff deadline. SO WHAT: If you purchased DMC Global securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the DMC Global class action, go to https://rosenlegal.com/submit-form/?case_id=32173…
Philadelphia, Pennsylvania–(Newsfile Corp. – December 29, 2024) – A securities class action lawsuit has been filed against Evolv Technologies Holdings, Inc. (“Evolv” or the “Company”) (NASDAQ: EVLV). The lawsuit has been filed on behalf of purchasers of EVOLV securities between August 19, 2022 and October 30, 2024, inclusive (the “Class Period”).CLICK HERE TO LEARN MORE ABOUT THIS LAWSUIT. Investors who purchased or acquired EVOLV securities during the Class Period may, no later than DECEMBER 31, 2024, seek to be appointed as a lead plaintiff representative of the class. Headquartered in Waltham, MA, Evolv is a security technology company that utilizes…
New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of ASML Holding N.V. (NASDAQ: AS:) between January 24, 2024 and October 15, 2024, both dates inclusive (the “Class Period”), of the important January 13, 2025 lead plaintiff deadline. SO WHAT: If you purchased ASML ordinary shares during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the ASML class action, go to https://rosenlegal.com/submit-form/?case_id=31159…
New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Celsius Holdings , Inc. (NASDAQ: NASDAQ:) between February 29, 2024 and September 4, 2024, both dates inclusive (the “Class Period”), of the important January 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Celsius common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Celsius class action, go to https://rosenlegal.com/submit-form/?case_id=31677…
New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Mynaric (ETR:) AG (NASDAQ: MYNA) between June 20, 2024 and October 7, 2024, both dates inclusive (the “Class Period”), of the important December 30, 2024 lead plaintiff deadline. SO WHAT: If you purchased Mynaric securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Mynaric class action, go to https://rosenlegal.com/submit-form/?case_id=32182 or call…
U.Today – There’s been some unusual activity in the (BTC) market this weekend, as in the last two days a new wallet has withdrawn 2,700 BTC, worth about $256.38 million, from Binance, the world’s largest cryptocurrency exchange. First, this wallet withdrew 1,000 BTC worth $94.43 million yesterday. Less than a day later, another transfer of 1,700 BTC worth $161.35 million left the exchange. Now the wallet holds 2,700 BTC, which is a lot of cash to move around in such a short amount of time. What’s even more interesting is that this unknown wallet came out of nowhere with no…
New York, New York–(Newsfile Corp. – December 29, 2024) – WHY:Rosen Law Firm, a global investor rights law firm, reminds purchasers of PACS Group Inc. (NYSE: PACS) of (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) in connection with the Company’s April 11, 2024 initial public offering (“IPO”); (ii) securities between April 11, 2024 and November 5, 2024, both dates inclusive (the “Class Period”); and/or (iii) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s September 2024 secondary public offering (“SPO”), of the important…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Kyverna To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 investing Kyverna common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about February 8, 2024 (the “IPO” or “Offering”) and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York–(Newsfile…